Caricamento...
Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. The disease is induced by antibodies, which are directed against the podocyte protein phospholipase A(2) receptor 1 (PLA(2)R1-ab) in 80% of cases. B cell depleting treatments, most notably rituximab, a chimeric CD20-antib...
Salvato in:
| Pubblicato in: | J Nephrol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036191/ https://ncbi.nlm.nih.gov/pubmed/33026632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-020-00874-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|